The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 146, Issue 8, Pages 2296-2304
Publisher
Wiley
Online
2020-01-04
DOI
10.1002/ijc.32857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact of tumor-stroma ratio in oral squamous cell carcinoma - A pilot study
- (2018) Kochli Channappa Niranjan et al. Annals of Diagnostic Pathology
- CD10 + GPR77 + Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
- (2018) Shicheng Su et al. CELL
- Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations
- (2018) G. W. van Pelt et al. VIRCHOWS ARCHIV
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
- (2018) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival
- (2018) Marcelo Sobral-Leite et al. OncoImmunology
- The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
- (2018) C. J. H. Kramer et al. BREAST CANCER RESEARCH AND TREATMENT
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor-Stroma Ratio is an independent predictor for overall survival and disease free survival in gastric cancer patients
- (2017) Paolo Aurello et al. SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND
- Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival
- (2017) Ke-Xing Xi et al. Journal of Thoracic Disease
- Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study
- (2017) René Scheer et al. World Journal of Gastrointestinal Oncology
- Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study
- (2016) F. J. Vogelaar et al. CELLULAR ONCOLOGY
- Prognostic Evaluation of Tumor-Stroma Ratio in Patients with Early Stage Cervical Adenocarcinoma Treated by Surgery
- (2015) Tip Pongsuvareeyakul et al. Asian Pacific Journal of Cancer Prevention
- Tumor–stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation
- (2015) Zhen Lv et al. SURGERY
- Prognostic Significance of the Tumor-Stroma Ratio in Epithelial Ovarian Cancer
- (2015) Ying Chen et al. Biomed Research International
- The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer
- (2014) J. H. Park et al. ANNALS OF ONCOLOGY
- The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer
- (2014) F J A Gujam et al. BRITISH JOURNAL OF CANCER
- Multicenter Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) Identifies Proteomic Differences in Breast-Cancer-Associated Stroma
- (2014) Tim J. A. Dekker et al. JOURNAL OF PROTEOME RESEARCH
- The Tumor-Stroma Ratio Is an Independent Predictor for Survival in Nasopharyngeal Cancer
- (2014) Xing-Lin Zhang et al. Oncology Research and Treatment
- Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
- (2013) T. J. A. Dekker et al. BREAST CANCER RESEARCH AND TREATMENT
- Tumor–stroma ratio is an independent predictor for survival in early cervical carcinoma
- (2013) Jing Liu et al. GYNECOLOGIC ONCOLOGY
- The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial
- (2012) A. Huijbers et al. ANNALS OF ONCOLOGY
- The prognostic value of tumour-stroma ratio in triple-negative breast cancer
- (2012) A.M. Moorman et al. EJSO
- Tumor-Stroma Ratio Is an Independent Predictor for Survival in Esophageal Squamous Cell Carcinoma
- (2012) kai Wang et al. Journal of Thoracic Oncology
- The prognostic significance of tumor-associated stroma in invasive breast carcinoma
- (2012) Soomin Ahn et al. TUMOR BIOLOGY
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients
- (2010) Esther M. de Kruijf et al. BREAST CANCER RESEARCH AND TREATMENT
- The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients
- (2010) N P West et al. BRITISH JOURNAL OF CANCER
- Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsies
- (2010) Ewout F.W. Courrech Staal et al. EUROPEAN JOURNAL OF CANCER
- Activation of Host Wound Responses in Breast Cancer Microenvironment
- (2009) M. A. Troester et al. CLINICAL CANCER RESEARCH
- ONCOPOOL – A European database for 16,944 cases of breast cancer
- (2009) R.W. Blamey et al. EUROPEAN JOURNAL OF CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search